220 related articles for article (PubMed ID: 30815157)
1. Multi-View Graph Convolutional Network and Its Applications on Neuroimage Analysis for Parkinson's Disease.
Zhang X; He L; Chen K; Luo Y; Zhou J; Wang F
AMIA Annu Symp Proc; 2018; 2018():1147-1156. PubMed ID: 30815157
[TBL] [Abstract][Full Text] [Related]
2. Parkinson's Disease Recognition Using Decorrelated Convolutional Neural Networks: Addressing Imbalance and Scanner Bias in rs-fMRI Data.
Patil P; Ford WR
Biosensors (Basel); 2024 May; 14(5):. PubMed ID: 38785733
[TBL] [Abstract][Full Text] [Related]
3. Predictive Big Data Analytics: A Study of Parkinson's Disease Using Large, Complex, Heterogeneous, Incongruent, Multi-Source and Incomplete Observations.
Dinov ID; Heavner B; Tang M; Glusman G; Chard K; Darcy M; Madduri R; Pa J; Spino C; Kesselman C; Foster I; Deutsch EW; Price ND; Van Horn JD; Ames J; Clark K; Hood L; Hampstead BM; Dauer W; Toga AW
PLoS One; 2016; 11(8):e0157077. PubMed ID: 27494614
[TBL] [Abstract][Full Text] [Related]
4. Bridging Imaging and Clinical Scores in Parkinson's Progression via Multimodal Self-Supervised Deep Learning.
Martinez-Murcia FJ; Arco JE; Jimenez-Mesa C; Segovia F; Illan IA; Ramirez J; Gorriz JM
Int J Neural Syst; 2024 Aug; 34(8):2450043. PubMed ID: 38770651
[TBL] [Abstract][Full Text] [Related]
5. A multilevel-ROI-features-based machine learning method for detection of morphometric biomarkers in Parkinson's disease.
Peng B; Wang S; Zhou Z; Liu Y; Tong B; Zhang T; Dai Y
Neurosci Lett; 2017 Jun; 651():88-94. PubMed ID: 28435046
[TBL] [Abstract][Full Text] [Related]
6. Data-Driven Subtyping of Parkinson's Disease Using Longitudinal Clinical Records: A Cohort Study.
Zhang X; Chou J; Liang J; Xiao C; Zhao Y; Sarva H; Henchcliffe C; Wang F
Sci Rep; 2019 Jan; 9(1):797. PubMed ID: 30692568
[TBL] [Abstract][Full Text] [Related]
7. Predictive markers for Parkinson's disease using deep neural nets on neuromelanin sensitive MRI.
Shinde S; Prasad S; Saboo Y; Kaushick R; Saini J; Pal PK; Ingalhalikar M
Neuroimage Clin; 2019; 22():101748. PubMed ID: 30870733
[TBL] [Abstract][Full Text] [Related]
8. MNC-Net: Multi-task graph structure learning based on node clustering for early Parkinson's disease diagnosis.
Huang L; Ye X; Yang M; Pan L; Zheng SH
Comput Biol Med; 2023 Jan; 152():106308. PubMed ID: 36462371
[TBL] [Abstract][Full Text] [Related]
9. Effect of data leakage in brain MRI classification using 2D convolutional neural networks.
Yagis E; Atnafu SW; García Seco de Herrera A; Marzi C; Scheda R; Giannelli M; Tessa C; Citi L; Diciotti S
Sci Rep; 2021 Nov; 11(1):22544. PubMed ID: 34799630
[TBL] [Abstract][Full Text] [Related]
10. Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson's disease: a longitudinal cohort study and validation.
Latourelle JC; Beste MT; Hadzi TC; Miller RE; Oppenheim JN; Valko MP; Wuest DM; Church BW; Khalil IG; Hayete B; Venuto CS
Lancet Neurol; 2017 Nov; 16(11):908-916. PubMed ID: 28958801
[TBL] [Abstract][Full Text] [Related]
11. Developing a Dynamic Graph Network for Interpretable Analysis of Multi-Modal MRI Data in Parkinson's Disease Diagnosis.
Li F; Wang Z; Guo Y; Liu C; Zhu Y; Zhou Y; Li J; Liang D; Wang H
Annu Int Conf IEEE Eng Med Biol Soc; 2023 Jul; 2023():1-4. PubMed ID: 38083052
[TBL] [Abstract][Full Text] [Related]
12. Combining Neuroimaging and Omics Datasets for Disease Classification Using Graph Neural Networks.
Chan YH; Wang C; Soh WK; Rajapakse JC
Front Neurosci; 2022; 16():866666. PubMed ID: 35677355
[TBL] [Abstract][Full Text] [Related]
13. COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global--clinical evaluations, serum biomarkers, genetic studies and neuroimaging--prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression.
Santos-García D; Mir P; Cubo E; Vela L; Rodríguez-Oroz MC; Martí MJ; Arbelo JM; Infante J; Kulisevsky J; Martínez-Martín P;
BMC Neurol; 2016 Feb; 16():26. PubMed ID: 26911448
[TBL] [Abstract][Full Text] [Related]
14. Automatic classification of dopamine transporter SPECT: deep convolutional neural networks can be trained to be robust with respect to variable image characteristics.
Wenzel M; Milletari F; Krüger J; Lange C; Schenk M; Apostolova I; Klutmann S; Ehrenburg M; Buchert R
Eur J Nucl Med Mol Imaging; 2019 Dec; 46(13):2800-2811. PubMed ID: 31473800
[TBL] [Abstract][Full Text] [Related]
15. Relationship between cerebrospinal fluid biomarkers and structural brain network properties in Parkinson's disease.
Abbasi N; Mohajer B; Abbasi S; Hasanabadi P; Abdolalizadeh A; Rajimehr R
Mov Disord; 2018 Mar; 33(3):431-439. PubMed ID: 29436735
[TBL] [Abstract][Full Text] [Related]
16. The exploration of Parkinson's disease: a multi-modal data analysis of resting functional magnetic resonance imaging and gene data.
Bi XA; Wu H; Xie Y; Zhang L; Luo X; Fu Y;
Brain Imaging Behav; 2021 Aug; 15(4):1986-1996. PubMed ID: 32990896
[TBL] [Abstract][Full Text] [Related]
17. Graph theory and network topological metrics may be the potential biomarker in Parkinson's disease.
Huang LC; Wu PA; Lin SZ; Pang CY; Chen SY
J Clin Neurosci; 2019 Oct; 68():235-242. PubMed ID: 31420273
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Anatomical and Diffusion MRI for detecting Parkinson's Disease using Deep Convolutional Neural Network.
Chattopadhyay T; Singh A; Laltoo E; Boyle CP; Owens-Walton C; Chen YL; Cook P; McMillan C; Tsai CC; Wang JJ; Wu YR; van der Werf Y; Thompson PM
Annu Int Conf IEEE Eng Med Biol Soc; 2023 Jul; 2023():1-6. PubMed ID: 38083460
[TBL] [Abstract][Full Text] [Related]
19. Complex networks reveal early MRI markers of Parkinson's disease.
Amoroso N; La Rocca M; Monaco A; Bellotti R; Tangaro S
Med Image Anal; 2018 Aug; 48():12-24. PubMed ID: 29807313
[TBL] [Abstract][Full Text] [Related]
20. Parkinson's disease: Cause factors, measurable indicators, and early diagnosis.
Bhat S; Acharya UR; Hagiwara Y; Dadmehr N; Adeli H
Comput Biol Med; 2018 Nov; 102():234-241. PubMed ID: 30253869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
